April 26, 2018 / 8:14 PM / 7 months ago

CORRECTED-Vertex Pharma's quarterly profit falls 15.1 percent

(Corrects to say revenue fell, not rose, in paragraph 3)

April 26 (Reuters) - Vertex Pharmaceuticals Inc's quarterly profit fell 15.1 percent, hurt by higher research and development spending.

Vertex said on Thursday income attributable to the company fell to $210.3 million or 81 cents per share in the three months ended March 31, from $247.8 million or 99 cents per share, a year earlier.

Vertex, one of the top U.S. manufacturers of treatments for lung disorder cystic fibrosis, said its revenue fell to $640.8 million from $714.7 million.

The company also separately said it had begun a late-stage study of a triple combination treatment for cystic fibrosis. (Reporting by Manas Mishra in Bengaluru; Editing by Sai Sachin Ravikumar)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below